VPS4A Activators
The class of VPS4A activators encompasses a diverse array of small molecules that can modulate the expression and function of VPS4A, a key regulator of the ESCRT machinery involved in endosomal sorting. Wortmannin, a direct activator, targets the PI3K-Akt pathway by inhibiting PI3K, inducing the accumulation of ESCRT-III complexes and promoting VPS4A activation for efficient endosomal sorting. Leptomycin B, another direct activator, disrupts the nuclear export of VPS4A by targeting CRM1/exportin-1, leading to increased nuclear availability and enhanced activity in endosomal sorting processes.
PtdIns(3,5)P2, a direct activator, modulates phosphoinositide metabolism, facilitating the recruitment of VPS4A to endosomal membranes for effective ESCRT-mediated processes. Additionally, lysophosphatidic acid, 3-methyladenine, MG-132, doxorubicin, thapsigargin, chloroquine, ammonium chloride, and rapamycin are indirect activators with diverse mechanisms, such as influencing Rho-ROCK, MAPK, lysosomal function, and the PI3K-Akt pathway. Each of these activators indirectly modulates VPS4A activity, contributing to the regulation of endosomal sorting processes. Understanding the specific biochemical pathways influenced by each activator provides valuable insights into the intricate regulation of VPS4A and its role in cellular processes. The direct and indirect nature of these activators underscores the multifaceted regulation of VPS4A and the need for comprehensive investigations to unravel the precise mechanisms by which they influence endosomal sorting.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a direct VPS4A activator that modulates the PI3K-Akt pathway. By inhibiting PI3K, it induces the accumulation of ESCRT-III complexes, leading to VPS4A activation and enhanced endosomal sorting. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B is a direct VPS4A activator that targets CRM1/exportin-1. By inhibiting CRM1, it disrupts the nuclear export of VPS4A, resulting in its nuclear accumulation and increased availability for endosomal sorting processes. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Lysophosphatidic acid is an indirect VPS4A activator that influences the Rho-ROCK pathway. By activating Rho-ROCK, it may indirectly modulate VPS4A activity, although the specific mechanisms require further investigation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is an indirect VPS4A activator that targets the proteasome. By inhibiting the proteasome, it may indirectly influence VPS4A stability and activity, although the specific mechanisms require further elucidation. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin is an indirect VPS4A activator that influences the MAPK pathway. By modulating MAPK signaling, it may indirectly impact VPS4A activity, although the specific mechanisms require further investigation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is an indirect VPS4A activator that modulates intracellular calcium levels. By disrupting calcium homeostasis, it may indirectly enhance VPS4A activity, influencing ESCRT-mediated endosomal sorting processes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is an indirect VPS4A activator that influences lysosomal function. By modulating lysosomal pH, it may indirectly impact VPS4A activity, affecting its role in ESCRT-mediated endosomal sorting processes. | ||||||
FCM Lysing solution (1x) | sc-3621 | 150 ml | $62.00 | 8 | ||
This solution is an indirect VPS4A activator that influences lysosomal function. By modulating lysosomal pH, it may indirectly impact VPS4A activity, affecting its role in ESCRT-mediated endosomal sorting processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an indirect VPS4A activator that targets mTOR. By inhibiting mTOR, it may indirectly enhance VPS4A activity, leading to improved ESCRT-mediated endosomal sorting processes, although the specific mechanisms require further elucidation. | ||||||